Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience-Reference-Cited by-同舟云学术

Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience

Published:2008-03 Issue:2 Volume:14 Page:260-270
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

NEUNERT C. E.,MILLER K. L.,JOURNEYCAKE J. M.,BUCHANAN G. R.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01605.x/fullpdf

Reference157 articles.

1. Use of central venous catheters in children with severe congenital coagulopathy

2. Central venous access devices in haemophilia

3. Consensus recommendations for use of central venous access devices in haemophilia

4. The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications

5. Experience With Recombinant Factor VIIA in an Infant Hemophiliac With Inhibitors to FVIILC Undergoing Emergency Central Line Placement

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China;Heliyon;2023-03

2. Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia;BMC Pediatrics;2022-03-12

3. Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia;The Journal of Haemophilia Practice;2022-01-01

4. Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients;British Journal of Clinical Pharmacology;2021-05-04

5. Correction of haemostasis can be reduced to four days for CVAD implantation in severe haemophilia A patients: Data from the PedNet study group;Haemophilia;2021-03-21